Research

Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation. Read More

The Vanderbilt Institute for Global Health (VIGH) has received two new grants from the Fogarty International Center of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Zambia, Mozambique and Brazil. Read More

Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment. Read More

The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes. Read More

Recent microbiological research has shown that plants and animals, including humans, are not autonomous individuals but are holobionts: biomolecular networks that consist of visible hosts plus millions of invisible microbes. Read More

Janos Sztipanovits wants to connect the whole world to the internet--and that means not just people, but clothes dryers, traffic lights and smoke detectors, too. Read More

The Mid-South Clinical Data Research Network, led by Vanderbilt University’s Russell Rothman, M.D., M.P.P., has been approved for a three-year, $8.5 million funding award from the independent Patient-Centered Outcomes Research Institute (PCORI) to expand its efforts to improve healthcare throughout the Southeast. Read More

Vanderbilt’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.” Read More

A team of Vanderbilt and Nashville VA researchers, led by Adriana Hung, M.D., MPH, has been awarded a grant from the U.S. Department of Veterans Affairs to use the Million Veteran Program (MVP) data to conduct diabetes research. Read More

The Administration on Intellectual and Developmental Disabilities has awarded a five-year, $2.7 million grant to continue the University Center for Excellence in Developmental Disabilities (UCEDD) at the Vanderbilt Kennedy Center (VKC). Read More

Researchers at Vanderbilt University for the first time have demonstrated in a mouse model that aggregation, the “clumping together” of abnormal proteins, can contribute to a severe form of genetic epilepsy. Read More

New findings show that fibrin, a protein that was thought to play a key role in fracture healing, is not required, shifting understanding of how fractures heal. Read More

Vanderbilt researchers are exploring how neuroblastoma tumors begin and progress, knowledge that could provide new treatments for this pediatric cancer. Read More

Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities. Read More

Vanderbilt researchers have discovered how certain molecules with antibiotic properties are synthesized, findings that could lead to new drugs that overcome the increased antibiotic resistance in bacteria. Read More

Vanderbilt scientists have discovered a new molecular mechanism that promotes stomach cancer development, findings that could provide new opportunities for treatment. Read More

Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known. Read More

Russell Rothman, M.D., MPP, professor of Medicine, Pediatrics and Health Policy, chief of the Section of Internal Medicine and Pediatrics and director of the Vanderbilt Center for Health Services Research, has been named assistant vice chancellor for Population Health Research. Read More

Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities. Read More

Vanderbilt’s Department of Radiology and Radiological Sciences has launched the Vanderbilt Clinical Trials Radiology Support Core. Read More